Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults

ClinicalTrials.gov ID: NCT05297578

Public ClinicalTrials.gov record NCT05297578. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 12:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Observer-Blind, Dose-Finding, Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Adults 65 Years and Older

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to evaluate the safety and tolerability of a single injection of VAX-24 at 3 dose levels compared to Prevnar 20™ (PCV20) in adults 65 years of age and older.

Study identification

NCT ID
NCT05297578
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vaxcyte, Inc.
Industry
Enrollment
207 participants

Conditions and interventions

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 15, 2022 (Actual)
Primary completion
Feb 15, 2023 (Actual)
Completion
Feb 15, 2023 (Actual)
Last update posted
Oct 9, 2024

2022 – 2023

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Accel Research Sites-Birmingham Clinical Research Unit Birmingham Alabama 35216 —
Accel Research Sites - DeLand Clinical Research Unit DeLand Florida 32720 —
CenExel RCA Hollywood Florida 33024 —
Precision Clinical Research Sunrise Florida 33351 —
Meridian Clinical Research Savannah Georgia 31406 —
Pivotal Research Solutions Stonecrest Georgia 30038 —
Healthcare Research Network II, LLC Flossmoor Illinois 60422 —
AMR Newton, formerly Heartland Research Associates Newton Kansas 67114 —
AMR Wichita West Wichita Kansas 67205 —
AMR New Orleans New Orleans Louisiana 70119 —
Healthcare Research Network Hazelwood Missouri 63042 —
Meridian Clinical Research Omaha Nebraska 68134 —
Accellacare of Rocky Mount Rocky Mount North Carolina 27804 —
Meridian Clinical Research Cincinnati Ohio 45219 —
Accellacare of Charleston Mt. Pleasant South Carolina 29464 —
Coastal Carolina Research North Charleston South Carolina 29405 —
Clinical Trials of Texas, LLC San Antonio Texas 78229 —
CenExel JBR Clinical Research Salt Lake City Utah 84107 —
Velocity Clinical Research, Salt Lake City West Jordan Utah 84088 —
Charlottesville Medical Research Charlottesville Virginia 22911 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05297578, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2024 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05297578 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →